 |
Ben Butkus is senior editor of GenomeWeb's premium content and the editor of PCR Insider. He covers technologies and trends in PCR, qPCR, nucleic acid amplification, and sample prep. E-mail Ben Butkus or follow his GenomeWeb Twitter account at @PCRInsider. |
NetBio Says Multiple-Biomarker Chlamydia Assay Outperforms Established Commercial Test
January 03, 2013
NetBio Says Multiple-Biomarker Chlamydia Assay Outperforms Established Commercial Test
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Team Developing Network Biosystems MDx Platform for Biothreat Testing Under Five-Year NIH Grant
June 14, 2012 / PCR Insider - Network Biosystems Begins Phase II SBIR Project for STD Dx; Plans Human ID System Launch this Year
March 22, 2012 / PCR Insider - Cepheid Highlights Strong Uptake of Xpert CT/NG as Q1 Revenues Rise 19 Percent
April 25, 2013 / PCR Insider - On Heels of FDA Approval, Cepheid's Xpert CT/NG Test Performs Well in Multi-Center Clinical Study
March 14, 2013 / PCR Insider - PerkinElmer Buys Shanghai Haoyuan for Near-Term Blood Screening Play, Longer Term MDx Initiative
November 15, 2012 / PCR Insider